Stockscreener 앱 받기
0.65
1.22%
-0.008
전일 마감가:
$0.658
열려 있는:
$0.6637
하루 거래량:
167.61K
Relative Volume:
0.32
시가총액:
$64.91M
수익:
$38.70M
순이익/손실:
$-117.88M
주가수익비율:
-0.3824
EPS:
-1.7
순현금흐름:
$-92.84M
1주 성능:
-2.84%
1개월 성능:
-6.29%
6개월 성능:
-32.29%
1년 성능:
-51.49%
1일 변동 폭
$0.6421
$0.666
1주일 범위
$0.625
$0.684
52주 변동 폭
$0.4471
$1.70
Adicet Bio Inc Stock (ACET) Company Profile
명칭
Adicet Bio Inc
전화
617-482-2333
주소
131 DARTMOUTH STREET, BOSTON
ACET을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACET
Adicet Bio Inc
|
0.6484 | 64.91M | 38.70M | -117.88M | -92.84M | -1.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.81 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
518.70 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
319.52 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
560.23 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
261.05 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Adicet Bio Inc Stock (ACET) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-30 | 재개 | Guggenheim | Buy |
| 2024-09-11 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-06-27 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-06-27 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2023-06-01 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-09-21 | 개시 | JP Morgan | Overweight |
| 2022-03-31 | 개시 | SMBC Nikko | Outperform |
| 2022-03-08 | 개시 | Truist | Buy |
| 2022-03-04 | 개시 | Jefferies | Buy |
| 2021-05-18 | 개시 | BTIG Research | Buy |
| 2021-04-23 | 개시 | H.C. Wainwright | Buy |
| 2021-04-14 | 개시 | Canaccord Genuity | Buy |
| 2021-04-08 | 개시 | Guggenheim | Buy |
| 2020-11-04 | 개시 | B. Riley Securities | Buy |
| 2020-10-27 | 개시 | JMP Securities | Mkt Outperform |
| 2020-10-16 | 개시 | Wedbush | Outperform |
모두보기
Adicet Bio Inc 주식(ACET)의 최신 뉴스
Adicet Bio Elects Directors and Approves Key Proposals - TipRanks
Adicet Bio, Inc. (NASDAQ:ACET) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Squarepoint Ops LLC Purchases New Shares in Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
Adicet Bio To Present At Jefferies Global Healthcare Conference; Webcast At 4:20 PM ET - Nasdaq
Northern Trust Corp Acquires 28,153 Shares of Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
ACETAdicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates - Revista ADVFN
Millennium Management LLC Lowers Position in Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
Adicet Bio to Participate in a Fireside Chat at the 2025 Jefferies Global Healthcare Conference - Business Wire
Adicet Bio’s SWOT analysis: gamma-delta T cell therapy stock faces pivotal year - Investing.com
Adicet Bio, Inc. (NASDAQ:ACET) Shares Sold by D. E. Shaw & Co. Inc. - Defense World
Financial Comparison: Adicet Bio (NASDAQ:ACET) & Trevena (NASDAQ:TRVN) - Defense World
Brokerages Set Adicet Bio, Inc. (NASDAQ:ACET) Price Target at $7.50 - Defense World
Adicet Bio (ACET) Upgraded to Buy: Here's What You Should Know - MSN
Adicet Bio (NASDAQ:ACET) Coverage Initiated at StockNews.com - Defense World
Wedbush Comments on Adicet Bio’s Q3 Earnings (NASDAQ:ACET) - Defense World
What is Wedbush’s Estimate for Adicet Bio Q1 Earnings? - Defense World
Adicet Bio Reports Q1 2025 Results and Updates - TipRanks
Marshall Wace LLP Sells 104,894 Shares of Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates - Bluefield Daily Telegraph
ACET's Cash Reserves Expected to Sustain Operations Until Late 2 - GuruFocus
Adicet Bio, Inc. (NASDAQ:ACET) Shares Acquired by JPMorgan Chase & Co. - Defense World
Reviewing Adicet Bio (NASDAQ:ACET) and HUTCHMED (NASDAQ:HCM) - Defense World
Renaissance Technologies LLC Has $882,000 Holdings in Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
Adicet Bio, Inc. (NASDAQ:ACET) Short Interest Update - Defense World
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference - Yahoo Finance
Adicet Bio (NASDAQ:ACET) Rating Increased to Hold at StockNews.com - Defense World
Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting - BioSpace
Adicet Bio Announces Oral Presentation Highlighting Preclinical Adi-270 Data At The American Society Of Gene And Cell Therapy 28Th Annual Meeting - marketscreener.com
We're Keeping An Eye On Adicet Bio's (NASDAQ:ACET) Cash Burn Rate - Yahoo Finance
JMP maintains Market Perform on Adicet Bio shares By Investing.com - Investing.com Canada
JMP maintains Market Perform on Adicet Bio shares - Investing.com
Adicet Bio (NASDAQ:ACET) Now Covered by StockNews.com - Defense World
Adicet Bio appoints Michael Grissinger to its board By Investing.com - Investing.com Canada
Adicet Bio Appoints Michael Grissinger to the Board of Directors - BioSpace
Adicet Bio appoints Michael Grissinger to its board - Investing.com
Adicet Bio Appoints Michael Grissinger to Board - TipRanks
Adicet Bio Appoints Michael Grissinger To The Board Of Directors - marketscreener.com
Adicet Bio Strengthens Board with Ex-Johnson & Johnson VP: Strategic Move for Cell Therapy Pioneer - Stock Titan
Adicet Bio Inc (ACET) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.78%
1.26%
자본화:
|
볼륨(24시간):